Evidence map›Paper›PMID 38896142›Full record

ArticleJournal of cancer research and clinical oncology2024

Immune- and metabolism-related gene signature analysis uncovers the prognostic and immune microenvironments of hepatocellular carcinoma.

Yange Gu, Ensi Ma, Shengran Jiang, Zhenyu Shan, Guixi Xia, Rui Ma, Jiaqi Fu, Zhengxin Wang

Abstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yange Gu *Liver Transplantation Center, General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Ensi Ma *Liver Transplantation Center, General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Shengran Jiang *Liver Transplantation Center, General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Zhenyu ShanBengbu Medical University, Bengbu, China.
Guixi XiaBengbu Medical University, Bengbu, China.
Rui MaBengbu Medical University, Bengbu, China.
Jiaqi FuBengbu Medical University, Bengbu, China.
Zhengxin WangLiver Transplantation Center, General Surgery, Huashan Hospital, Fudan University, Shanghai, China. wangzhengxin@huashan.org.cn.

Funding

National Key Research and Development Program of China 2023YFC2505900National Natural Science Foundation of China 82241225
6 · The paper itself

Abstract

backgroundMetabolic reprogramming is an emerging hallmark that influences the tumour microenvironment (TME) by regulating the behavior of cancer cells and immune cells. The relationship between metabolism and immunity remains elusive. The purpose of this study was to explore the predictive value of immune- and metabolism-related genes in hepatocellular carcinoma (HCC) and their intricate interplay with TME.

methodsWe established the immune- and metabolism-related signature (IMRPS) based on the LIHC cohort from The Cancer Genome Atlas (TCGA) dataset. Kaplan-Meier analysis, receiver operating characteristic (ROC) curve analysis and Cox regression analysis confirmed the prognostic value of IMRPS. We investigated differences in immune cell infiltration, clinical features, and therapeutic response between risk groups. The quantitative real-time PCR (qPCR) was used to confirm the expression of signature genes. Immunohistochemical staining was performed to evaluate immune infiltration features in HCC tissue samples. We conducted cell experiments including gene knockout, cell counting kit-8 (CCK-8), and flow cytometry to explore the role of the IMRPS key gene UCK2 in HCC. RNA-seq was used to further investigate the potential underlying mechanism involved.

resultsThe IMRPS, composed of four genes, SMS, UCK2, PFKFB4 and MAPT, exhibited significant correlations with survival, immune cell infiltration, clinical features, immune checkpoints and therapeutic response. The IMRPS was shown to be an excellent predictor of HCC prognosis. It could stratify patients appropriately and characterize the TME accurately. The high-risk HCC group exhibited an immunosuppressive microenvironment with abundant M

conclusionsThis study established a new IMRS for the accurate prediction of patient prognosis and the TME, which is also helpful for identifying new targets for the treatment of HCC.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsTumor MicroenvironmentBiomarkers, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMiddle AgedPrognosisTranscriptomeBiomarkers, TumorHepatocellular carcinoma (HCC)ImmunityMetabolic reprogrammingSignatureTumour microenvironment (TME)

Identifiers

PMID38896142
PMCPMC11186947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.